Daniel Karen L
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Snap-on Faces Q3 Earnings Amid Data Center Speculation. Snap-on is preparing for its third-quarter earnings report, with market attention turning to whether rising data center demand could drive growth for its Torque division. The company continues to emphasize its long-standing dividend history, having paid consecutive dividends since 1939. With the stock trading at a P/E of 18.4 and a yield of 2.70%, investors are weighing these fundamentals against the upcoming financial results.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Teladoc Launches AI-Powered Remote Monitoring Tools. Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.
Transaction History
| CBSH | ▲ Buy | Grant | 886 | $46K | 5/29/2026 | View on chart |
| CBSH | ▲ Buy | Grant | 907 | $46K | 2/28/2026 | View on chart |
| SNA | ▲ Buy | Grant | 520 | — | 2/12/2026 | View on chart |
| CBSH | ▲ Buy | Grant | 858 | $46K | 11/30/2025 | View on chart |
| CBSH | ▲ Buy | Grant | 747 | $46K | 8/29/2025 | View on chart |
| SNA | ▼ Sell | Open Market | 1,090 | $349K | 6/5/2025 | View on chart |
| CBSH | ▲ Buy | Grant | 734 | $46K | 5/30/2025 | View on chart |
| CBSH | ▲ Buy | Grant | 576 | $37K | 2/28/2025 | View on chart |
| SNA | ▲ Buy | Grant | 493 | — | 2/13/2025 | View on chart |
| CBSH | ▲ Buy | Grant | 1,206 | $75K | 12/31/2024 | View on chart |
| CBSH | ▲ Buy | Grant | 216 | $14K | 10/31/2024 | View on chart |
| CBSH | ▲ Buy | Grant | 209 | $14K | 7/31/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 9,834 | $117K | 5/23/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 9,834 | — | 5/22/2024 | View on chart |
| CBSH | ▲ Buy | Grant | 247 | $14K | 4/30/2024 | View on chart |
| CBSH | ▲ Buy | Grant | 259 | $13K | 2/29/2024 | View on chart |
| SNA | ▲ Buy | Grant | 599 | — | 2/15/2024 | View on chart |
| CBSH | ▲ Buy | Grant | 1,406 | $75K | 12/29/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 14,073 | $301K | 12/20/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 436 | — | 11/17/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 307 | $13K | 10/31/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 254 | $14K | 7/31/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 21 | $1K | 5/31/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 6,726 | — | 5/24/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 224 | $13K | 4/28/2023 | View on chart |
| SNA | ▼ Sell | Open Market | 2,046 | $502K | 3/8/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 204 | $13K | 2/28/2023 | View on chart |
| SNA | ▲ Buy | Grant | 640 | — | 2/9/2023 | View on chart |
| CBSH | ▲ Buy | Grant | 737 | $50K | 12/30/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 436 | — | 11/18/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 190 | $13K | 10/31/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 182 | $13K | 8/31/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 14 | $969 | 5/31/2022 | View on chart |
| TDOC | ▼ Sell | Open Market | 410 | $13K | 5/19/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,638 | — | 5/17/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 183 | $13K | 4/29/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 188 | $13K | 2/28/2022 | View on chart |
| SNA | ▲ Buy | Grant | 725 | — | 2/10/2022 | View on chart |
| CBSH | ▲ Buy | Grant | 731 | $50K | 12/31/2021 | View on chart |
| SNA | ▼ Sell | Gift | 1,410 | — | 12/9/2021 | View on chart |
| SNA | ▼ Sell | Open Market | 2,259 | $482K | 12/9/2021 | View on chart |
| CBSH | ▲ Buy | Grant | 179 | $12K | 11/30/2021 | View on chart |
| TDOC | ▼ Sell | Open Market | 109 | $13K | 11/22/2021 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 436 | — | 11/19/2021 | View on chart |
| CBSH | ▲ Buy | Grant | 14 | $987 | 10/31/2021 | View on chart |
| SNA | ▼ Sell | Open Market | 3,219 | $716K | 9/9/2021 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 6,462 | — | 8/25/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
CBSH Gets Mixed Analyst Updates Amid Acquisition News
Commerce Bancshares completed the acquisition of Nolan & Associates and expanded its family banking services. Analyst views remain divided, with Piper Sandler and Wells Fargo lowering price targets, while Morgan Stanley raised its target to $77. The stock is currently trading near its 52-week low, reflecting mixed sentiment on its growth strategy.
CBSH Gets Mixed Analyst Updates Amid Acquisition News. Commerce Bancshares completed the acquisition of Nolan & Associates and expanded its family banking services. Analyst views remain divided, with Piper Sandler and Wells Fargo lowering price targets, while Morgan Stanley raised its target to $77. The stock is currently trading near its 52-week low, reflecting mixed sentiment on its growth strategy.